Invesco Biotechnology & Genome ETF (PBE) Holdings List

$96.72 +1.78 (+1.87%)

Closing price 04:10 PM Eastern

Extended Trading

$96.67 -0.05 (-0.05%)

As of 07:30 PM Eastern

What stocks does PBE hold?

The Invesco Biotechnology & Genome ETF (PBE) has 30 holdings, with Illumina, Natera, and Biogen among its largest positions. The top 25 PBE holdings ordered by weight make up 89.06% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 PBE Holdings

Rank	Company	Current Price	Weight	Shares Held
1	ILMN Illumina	$271.76 +0.2%	6.28%	95,180
2	NTRA Natera	$394.75 -0.2%	6.04%	63,598
3	BIIB Biogen	$232.83 +1.7%	5.31%	96,999
4	GILD Gilead Sciences	$153.54 +3.8%	5.17%	143,942
5	AMGN Amgen	$426.11 +3.2%	4.83%	48,422
6	RPRX Royalty Pharma	$58.99 +4.3%	4.76%	345,003
7	VRTX Vertex Pharmaceuticals	$498.50 +2.7%	4.69%	38,735
8	REGN Regeneron Pharmaceuticals	$778.36 +3.4%	4.68%	25,690
9	MRNA Moderna	$226.30 +4.6%	3.75%	73,546
10	NVAX Novavax	$12.64 -1.4%	3.74%	1,237,348
Get the Latest News and Ratings for PBE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.
11	UTHR United Therapeutics	$540.03 -0.6%	2.96%	22,527
12	EXEL Exelixis	$60.99 +2.5%	2.94%	205,933
13	QGEN Qiagen	$45.54 +0.2%	2.89%	267,595
14	HALO Halozyme Therapeutics	$116.82 +6.6%	2.83%	106,848
15	VCYT Veracyte	$43.51 +0.9%	2.79%	265,226
16	TGTX TG Therapeutics	$54.37 +0.1%	2.78%	210,764
17	PTGX Protagonist Therapeutics	$136.28 -1.6%	2.68%	77,565
18	RGEN Repligen	$178.20 +1.6%	2.65%	64,289
19	VCEL Vericel	$40.25 -0.1%	2.62%	270,258
20	NBIX Neurocrine Biosciences	$135.91 +0.6%	2.57%	76,161
21	SRPT Sarepta Therapeutics	$16.83 +1.9%	2.57%	617,365
22	INCY Incyte	$111.57 +2.7%	2.39%	90,045
23	PTCT PTC Therapeutics	$59.67 -0.4%	2.39%	158,985
24	ARDX Ardelyx	$3.19 +2.2%	2.38%	3,090,096
25	BCRX BioCryst Pharmaceuticals	$8.05 -0.2%	2.37%	1,188,257

PBE Geographic Exposure

PBE's largest geographic exposure is United States at 97.1%, followed by Netherlands at 3.0%.

United States
97.1%
Netherlands
3.0%

PBE Currency Exposure

PBE is exclusively exposed to USD.

USD
94.7%

PBE Sector Exposure

PBE's largest sector exposure is Health Care at 97.1%.

Health Care
97.1%

PBE Industry Exposure

PBE's largest industry exposure is Biotechnology at 79.3%, followed by Health Care Equipment & Supplies at 11.7%.

Biotechnology
79.3%
Health Care Equipment & Supplies
11.7%
Health Care Providers & Services
6.1%

PBE Sub-Industry Exposure

PBE's largest sub-industry exposure is Biotechnology at 79.3%, followed by Life Sciences Tools & Services at 11.7%.

Biotechnology
79.3%
Life Sciences Tools & Services
11.7%
Health Care Services
6.1%

Related Companies and Tools

Related Companies

MarketBeat tracks Invesco Biotechnology & Genome ETF holdings and portfolio composition, last updated on 10/14/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Invesco Biotechnology & Genome ETF (PBE) Holdings List